| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.31B | +99.3% |
| Gross profit | ¥0.13B | — |
| Operating income | ¥0.06B | — |
| Net income | ¥0.05B | +428.9% |
| Gross margin | 40.8% | Net margin 16.6% |
| Revenue Q/Q | +1.2% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.18B | 59.2% |
| R&D | ¥0.03B | 10.9% |
| SG&A | ¥0.03B | 9.2% |
| Tax & other | ¥0.01B | 2.1% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
万里马 ・ 华凯易佰 ・ 新雷能 ・ ST朗进 ・ 欧普康视 ・ 利安隆 ・ 吉大通信 ・ 诚迈科技 ・ 雄塑科技 ・ 国瑞科技 ・ 康泰生物 ・ 飞荣达
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies